|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - Par Pharmaceutical Companies I (PRX)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
Par Pharmaceutical Companies Inc: Insider Trading and Stock Options
Common stock purchase or sale:
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-08-25 Sale |
2009-08-26 2:22 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | HAUGHEY THOMAS (EVP, Chief Admin Off, Gen Cnsl) | 31,000 | $20.39 | $631,981 | 136,916 (Direct) | View |
| 2009-08-24 Sale | 2009-08-26 2:04 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Campanelli Paul (EVP, Pres. - Generics) | 31,234 | $20.25 | $632,469 | 115,144 (Direct) |
View |
| 2009-08-17- -2009-08-18 Sale | 2009-08-19 6:23 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Flynn James E DEERFIELD MANAGEMENT CO DEERFIELD INTERNATIONAL LTD (Possible Member of 10% Group 10% owner) | 240,416 | $17.64 | $4,241,140 | 2,108,213 (Indirect) |
View |
| 2008-11-25 Sale |
2008-12-01 4:28 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Flynn James E DEERFIELD CAPITAL LP DEERFIELD MANAGEMENT CO DEERFIELD INTERNATIONAL LTD (Possible Member of 10% Group 10% owner) | 173,500 | $10.44 | $1,811,510 | 2,348,629 (Indirect) | View |
| 2007-01-30- -2007-02-01 Sale | 2007-02-01 7:58 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Flynn James E DEERFIELD CAPITAL LP DEERFIELD PARTNERS, LP DEERFIELD MANAGEMENT CO DEERFIELD INTERNATIONAL LTD Deerfield Special Situations Fund, L.P. Deerfield Special Situations Fund International LTD (10% owner) | 632,047 | $26.87 | $16,982,566 | 2,173,177 (Indirect) | View |
| 2007-01-25 Purchase | 2007-01-31 9:29 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | SAC CAPITAL ADVISORS LLC S A C CAPITAL MANAGEMENT L L C CR Intrinsic Investors, LLC SIGMA CAPITAL MANAGEMENT LLC COHEN STEVEN A/SAC CAPITAL MGMT LP (10% owner) | 200 | $24.1 | $4,820 | 3,008,100 (Indirect) | View |
| 2006-07-18 Purchase |
2006-07-20 5:21 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Flynn James E DEERFIELD CAPITAL LP DEERFIELD PARTNERS, LP DEERFIELD MANAGEMENT CO DEERFIELD INTERNATIONAL LTD (10% owner) | 330,600 | $13.96 | $4,615,341 | 2,481,618 (Indirect) | View |
| 2006-01-26 Sale |
2006-01-30 2:07 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | GUTMAN ARIE (Former Director & Officer) | 6,700 | $31.6 | $211,720 | 0 (Direct) |
View |
Other purchase or sale (not a common stock or no ticker symbol):
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Ownership |
Filing |
| 2006-01-31 Sale |
2006-02-15 10:27 am |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | GUTMAN ARIE (Former director and officer) | 5,535 | $32.77 | $181,373 | 120 (Direct) | View |
Other transactions:
| Transaction & Date | Reported Date | Company | Symbol | Insider Relationship | Shares Traded |
Average Price | Total Amount |
Shares Ownership | Filing |
| 2009-10-30 Tax Withholding | 2009-11-02 5:16 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | LEPORE PATRICK G (Chairman, President and CEO Director) | 2,927 | $20.97 | $61,379 | 213,336 (Direct) |
View |
| 2009-09-09 Tax Withholding |
2009-09-10 4:06 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | MacPhee John A (EVP, Pres-Strativa) | 628 | $21.19 | $13,307 | 152,502 (Direct) |
View |
| 2009-08-10 Tax Withholding |
2009-08-12 10:37 am |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | LEPORE PATRICK G (Chairman, President & CEO Director) | 6,690 | $15.95 | $106,706 | 216,263 (Direct) |
View |
| 2009-03-23 Tax Withholding | 2009-03-24 5:40 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | MacPhee John A (EVP, Pres-Strativa) | 1,732 | $11.19 | $19,381 | 152,057 (Direct) | View |
| 2009-03-23 Tax Withholding |
2009-03-24 5:33 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | LEPORE PATRICK G (Chairman, President, CEO Director) | 1,890 | $11.19 | $21,149 | 222,324 (Direct) |
View |
| 2009-03-23 Tax Withholding | 2009-03-24 5:26 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | HAUGHEY THOMAS (EVP, CAO, General Counsel) | 2,359 | $11.19 | $26,397 | 167,916 (Direct) |
View |
| 2009-03-23 Tax Withholding | 2009-03-24 5:16 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Campanelli Paul (EVP, Pres-Generics) | 2,200 | $11.19 | $24,618 | 146,378 (Direct) | View |
| 2009-01-12 Tax Withholding |
2009-01-14 4:51 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | HAUGHEY THOMAS (EVP, Chief Admin Off, Gen Cnsl) | 1,017 | $12.59 | $12,804 | 170,275 (Direct) |
View |
| 2009-01-08 Option Award |
2009-01-12 5:13 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | KENYON LAWRENCE A (EVP Finance-Par Pharmaceutical) | 10,720 | $0 | $0 | 10,720 (Direct) | View |
| 2009-01-02 Tax Withholding | 2009-01-06 11:47 am | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Martino Gerard (Former EVP and COO) | 29,095 | $13.43 | $390,746 | 79,959 (Direct) | View |
| 2008-12-31 Tax Withholding | 2009-01-05 6:09 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | LUBATKIN VERONICA (EVP, Chief Financial Officer) | 20,140 | $13.41 | $270,077 | 50,606 (Direct) | View |
| 2007-01-31 Option Award | 2007-02-02 7:22 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | WILLIAMS PETER (Director) | 2,500 | $0 | $0 | 7,500 (Direct) |
View |
| 2006-01-26 Exercise | 2006-01-30 2:07 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | GUTMAN ARIE (Former Director & Officer) | 6,700 | $21.65 | $145,055 | 6,700 (Direct) | View |
| 2006-01-09 Option Award |
2006-01-11 7:46 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Graves Michael (Pres, Generic Products Div) | 19,838 | $0 | $0 | 37,869 (Direct) | View |
| 2006-01-09 Option Award | 2006-01-11 7:35 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Hariharan Shankar (VP, Chief Scientific Officer) | 30,066 | $0 | $0 | 90,066 (Direct) | View |
| 2006-01-09 Option Award |
2006-01-11 6:54 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | AUERBACH MARK (Executive Chairman Director) | 13,199 | $0 | $0 | 23,730 (Direct) |
View |
| 2006-01-09 Option Award | 2006-01-11 6:45 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | O CONNOR DENNIS J (Vice President, CFO) | 14,049 | $0 | $0 | 28,675 (Direct) |
View |
| 2006-01-09 Option Award |
2006-01-11 6:35 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | TARRIFF SCOTT L (President & CEO Director) | 26,399 | $0 | $0 | 47,461 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship | Shares Traded | Conversion Price | Shares Ownership |
Filing |
| 2009-10-05 Option Award | 2009-10-06 2:54 pm |
N/A N/A | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | SHAROKY MELVIN MD (Director) | 759 | $0 | 10,917 (Direct) | View |
| 2009-10-05 Option Award |
2009-10-06 2:46 pm |
N/A N/A |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | SMITH JOSEPH E (Director) | 1,168 | $0 | 19,972 (Direct) |
View |
| 2009-10-05 Option Award |
2009-10-06 2:24 pm | N/A N/A | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | KNIGHT PETER S (Director) | 759 | $0 | 16,221 (Direct) |
View |
| 2009-07-01 Option Award |
2009-07-02 09:42 am |
N/A N/A | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | SMITH JOSEPH E (Director) | 1,615 | $0 | 18,804 (Direct) | View |
| 2009-07-01 Option Award | 2009-07-02 09:34 am | N/A N/A | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | SHAROKY MELVIN MD (Director) | 1,050 | $0 | 10,158 (Direct) | View |
| 2009-07-01 Option Award | 2009-07-02 09:24 am | N/A N/A | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | KNIGHT PETER S (Director) | 1,050 | $0 | 15,462 (Direct) |
View |
| 2009-06-09 Option Award | 2009-06-15 11:30 am | 2010-06-09 N/A |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | RICE THOMAS P (Director) | 6,812 | $0 | 6,812 (Direct) | View |
| 2009-04-01 Option Award |
2009-04-03 5:06 pm | N/A N/A |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | SHAROKY MELVIN MD (Director) | 1,973 | $0 | 9,108 (Direct) | View |
| 2009-04-01 Option Award | 2009-04-03 5:00 pm | N/A N/A |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | KNIGHT PETER S (Director) | 1,832 | $0 | 14,412 (Direct) | View |
| 2009-04-01 Option Award | 2009-04-03 4:55 pm | N/A N/A | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | SMITH JOSEPH E (Director) | 2,678 | $0 | 17,190 (Direct) | View |
| 2008-01-07 Option Award |
2009-04-03 4:33 pm |
2009-01-07 N/A |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | SMITH JOSEPH E (Director) | 4,406 | $0 | 14,406 (Direct) |
View |
| 2009-01-08 Option Award |
2009-01-12 5:13 pm |
N/A 2019-01-08 |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | KENYON LAWRENCE A (EVP Finance-Par Pharmaceutical) | 85,758 | $13.06 | 85,758 (Direct) | View |
| 2009-01-08 Option Award |
2009-01-09 4:42 pm | 2010-01-08 N/A |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | ABERNATHY JOHN D (Director) | 7,657 | $0 | 19,563 (Direct) | View |
| 2009-01-08 Option Award |
2009-01-09 4:29 pm |
2010-01-08 N/A |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | SEIDMAN L WILLIAM (Director) | 7,657 | $0 | 19,563 (Direct) |
View |
| 2009-01-08 Option Award | 2009-01-09 4:15 pm | 2010-01-08 N/A |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | NORDMANN RONALD M (Director) | 7,657 | $0 | 19,563 (Direct) | View |
| 2007-01-31 Option Award |
2007-02-02 7:22 pm |
2008-01-31 2017-01-31 |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | WILLIAMS PETER (Director) | 5,000 | $26.38 | 5,000 (Direct) |
View |
| 2007-01-25 Purchase | 2007-01-31 9:29 pm | N/A 2008-01-19 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | SAC CAPITAL ADVISORS LLC S A C CAPITAL MANAGEMENT L L C CR Intrinsic Investors, LLC SIGMA CAPITAL MANAGEMENT LLC COHEN STEVEN A/SAC CAPITAL MGMT LP (10% owner) | 100 | $0 | 620,400 (Indirect) | View |
| 2007-01-25 Purchase | 2007-01-31 9:29 pm | N/A 2008-01-19 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | SAC CAPITAL ADVISORS LLC S A C CAPITAL MANAGEMENT L L C CR Intrinsic Investors, LLC SIGMA CAPITAL MANAGEMENT LLC COHEN STEVEN A/SAC CAPITAL MGMT LP (10% owner) | 200 | $0 | 620,600 (Indirect) |
View |
| 2006-01-26 Exercise | 2006-01-30 2:07 pm | N/A 2012-04-11 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | GUTMAN ARIE (Former Director & Officer) | 6,700 | $21.65 | 0 (Direct) | View |
| 2006-01-09 Option Award |
2006-01-11 7:46 pm | N/A 2016-01-09 |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Graves Michael (Pres, Generic Products Div) | 9,892 | $33.62 | 9,892 (Direct) | View |
| 2006-01-09 Option Award | 2006-01-11 7:35 pm | N/A 2016-01-09 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Hariharan Shankar (VP, Chief Scientific Officer) | 14,992 | $33.62 | 14,992 (Direct) |
View |
| 2006-01-09 Option Award |
2006-01-11 6:54 pm | N/A 2016-01-09 |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | AUERBACH MARK (Executive Chairman Director) | 59,971 | $33.62 | 59,971 (Direct) |
View |
| 2006-01-09 Option Award |
2006-01-11 6:45 pm | N/A 2016-01-09 |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | O CONNOR DENNIS J (Vice President, CFO) | 7,005 | $33.62 | 7,005 (Direct) | View |
| 2006-01-09 Option Award |
2006-01-11 6:35 pm | N/A 2016-01-09 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | TARRIFF SCOTT L (President & CEO Director) | 119,942 | $33.62 | 119,942 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sun, 08 Nov 2009 00:08:22 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |